Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis
- 1 November 2017
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 119 (5) , 441-445
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Toxicity of Eosinophil MBP Is Repressed by Intracellular Crystallization and Promoted by Extracellular AggregationMolecular Cell, 2015
- Th17 cells and tissue remodeling in atopic and contact dermatitisAllergy, 2013
- Extracellular DNA traps in allergic, infectious, and autoimmune diseasesAllergy, 2013
- Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in diseaseCurrent Opinion in Immunology, 2012
- Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular trapsAllergy, 2012
- Distinct eosinophil cytokine expression patterns in skin diseases – the possible existence of functionally different eosinophil subpopulationsAllergy, 2011
- Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostainingBritish Journal of Dermatology, 2001
- Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitisBritish Journal of Dermatology, 1992
- Dermal Deposition of Eosinophil-Granule Major Basic Protein in Atopic DermatitisNew England Journal of Medicine, 1985
- Clinical Aspects of Eosinophilia in Atopic DiseaseJAMA, 1967